Answers are grounded in this paper and cite their sources.
Background Mesenteric cystic lymphangiomas (MCLs) remain a clinical challenge when lesions are located in the mesentery with extension to the retroperitoneum. Although surgical resection represents the mainstream approach, complete excision of type 3 or type 4 MCL may be difficult or even impossible in certain patients. Therefore, sclerotherapy offers a feasible therapeutic option for these cases. Case presentation This report describes a neonate with type 3 MCL who underwent ultrasound-guided catheter drainage and intralesional sclerotherapy, achieving an excellent outcome and avoiding invasive surgical injury. A 1-day-old female neonate presented with abdominal distension and vomiting after initial feeding and was diagnosed with type 3 MCL by abdominal computed tomography. At postnatal ages 2 and 23 days, ultrasound-guided catheter drainage of the MCL was performed, with intracystic injection of bleomycin (concentration: 1 mg/mL, 0.5 mg/kg), respectively. The MCL regressed completely 1 year after sclerotherapy, and the patient was followed up for 3 years without recurrence. Conclusions Complete surgical resection of type 3 MCL may be difficult or even impossible and often causes severe trauma and complications. However, ultrasound-guided catheter drainage and bleomycin sclerotherapy as a minimally invasive approach is preferred because of its minimal invasiveness, repeatability, and reliable efficacy.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: